TauRx Pharmaceuticals Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:TauRx Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10629
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:シンガポール
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TauRx Pharmaceuticals Ltd (TauRx) discovers, develops and commercializes treatments and diagnostics for Alzheimer’s disease and other neurodegenerative diseases. Its pipeline products include LMTX, a tau aggregation inhibitor (TAI) for Alzheimer’s and Behavioural variant frontotemporal dementia diseases; and early-stage compounds for use in therapies for neurodegenerative diseases. TauRx novel tau aggregation inhibitors target the formation of tau protein tangles in the brain. The company operates a research facility located in Aberdeen, Scotland. It undertakes clinical trials for several drugs and works in partnership with academic institutions and other pharmaceutical companies active in the field of neurodegeneration. TauRx is headquartered in Singapore.

TauRx Pharmaceuticals Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TauRx Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TauRx Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TauRx Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TauRx Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TauRx Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 9
TauRx Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TauRx Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
TauRx Pharma Raises USD70 Million in Rights Offering of Shares 11
TauRx Pharma Plans IPO 12
TauRx Pharma Raises USD135 Million in Equity Financing 13
Acquisition 14
Dundee Acquires Minority Stake In TauRx Pharma For US$10.5 Million 14
Genting Invests US$32 Million In TauRx Pharma 15
TauRx Pharmaceuticals Ltd – Key Competitors 16
TauRx Pharmaceuticals Ltd – Key Employees 17
TauRx Pharmaceuticals Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
TauRx Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts 2
TauRx Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TauRx Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TauRx Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TauRx Pharmaceuticals Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
TauRx Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 9
TauRx Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TauRx Pharma Raises USD70 Million in Rights Offering of Shares 11
TauRx Pharma Plans IPO 12
TauRx Pharma Raises USD135 Million in Equity Financing 13
Dundee Acquires Minority Stake In TauRx Pharma For US$10.5 Million 14
Genting Invests US$32 Million In TauRx Pharma 15
TauRx Pharmaceuticals Ltd, Key Competitors 16
TauRx Pharmaceuticals Ltd, Key Employees 17
TauRx Pharmaceuticals Ltd, Subsidiaries 18

List of Figures
TauRx Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
TauRx Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
TauRx Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
TauRx Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
TauRx Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TauRx Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
TauRx Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TauRx Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TauRx Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[TauRx Pharmaceuticals Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Slanchev den AD Varna:企業の戦略・SWOT・財務情報
    Slanchev den AD Varna - Strategy, SWOT and Corporate Finance Report Summary Slanchev den AD Varna - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • GCL-Poly Energy Holdings Ltd:企業の発電所・SWOT分析2018
    GCL-Poly Energy Holdings Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • InMed Pharmaceuticals Inc (IN):企業の財務・戦略的SWOT分析
    Summary InMed Pharmaceuticals Inc (InMed), formerly Cannabis Technologies Inc, is a pre-clinical stage biopharmaceutical company which develops, produces and markets plant cannabinoid based medicines. The company's pipeline products include INM-750, INM-405, and INM-085. Its products finds applicati …
  • Nintendo Co Ltd (7974):企業の財務・戦略的SWOT分析
    Nintendo Co Ltd (7974) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Huawei Investment & Holding Co., Ltd.:企業のM&A・事業提携・投資動向
    Huawei Investment & Holding Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Huawei Investment & Holding Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • Komatsu Ltd.:企業の戦略・SWOT・財務情報
    Komatsu Ltd. - Strategy, SWOT and Corporate Finance Report Summary Komatsu Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Victory Resources Corporation:企業の戦略・SWOT・財務情報
    Victory Resources Corporation - Strategy, SWOT and Corporate Finance Report Summary Victory Resources Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • First Pacific Company Limited:企業の戦略・SWOT・財務情報
    First Pacific Company Limited - Strategy, SWOT and Corporate Finance Report Summary First Pacific Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Constellation Brands Inc (STZ):企業の財務・戦略的SWOT分析
    Constellation Brands Inc (STZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Global Blood Therapeutics Inc (GBT):製薬・医療:M&Aディール及び事業提携情報
    Summary Global Blood Therapeutics Inc (GBT) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes novel oral medicines for the treatment of grievous blood-based disorders. The company's lead drug candidate GBT440 is an oral, small molecule drug for the treatment o …
  • Aurobindo Pharma Ltd (AUROPHARMA)-製薬・医療分野:企業M&A・提携分析
    Summary Aurobindo Pharma Ltd (Aurobindo Pharma) is a pharmaceutical company which develops, manufactures and exports formulations and active pharmaceutical ingredients (API's). Its products portfolio include active pharma ingredients, formulations, antibiotics, anti-retrovirals, anti- allergics, gas …
  • Martinrea International Inc:企業の戦略・SWOT・財務分析
    Martinrea International Inc - Strategy, SWOT and Corporate Finance Report Summary Martinrea International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Coretex Products, Inc.:企業の戦略・SWOT・財務情報
    Coretex Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Coretex Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • NPC Co., Ltd.:企業の戦略・SWOT・財務情報
    NPC Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary NPC Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Telecom Argentina S.A.:戦略・SWOT・企業財務分析
    Telecom Argentina S.A. - Strategy, SWOT and Corporate Finance Report Summary Telecom Argentina S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Lycamobile UK Limited:企業の戦略的SWOT分析
    Lycamobile UK Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Cadila Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Cadila Pharmaceuticals Ltd (Cadila Pharmaceuticals) is a pharmaceutical company that develops, manufactures and distributes pharmaceutical products. The company's products include active pharmaceutical ingredients (API) and pharmaceutical formulations. Its business includes contract research …
  • Barnes Group Inc.:企業の戦略・SWOT・財務情報
    Barnes Group Inc. - Strategy, SWOT and Corporate Finance Report Summary Barnes Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Fidelity Investments Inc:企業の戦略・SWOT・財務情報
    Fidelity Investments Inc - Strategy, SWOT and Corporate Finance Report Summary Fidelity Investments Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Cardia Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cardia Inc (Cardia) is a medical device company that designs, manufactures and markets transcatheter septal occluders for cardiac defect patients. The company offers products such as ultrasept ASD occluder, ultrasept LAA occluder, ultrasept PFO occluder, fontan occluder, ultrasept cribriform …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆